Mizuho Initiates Coverage on Teladoc Health (NYSE:TDOC)

Key Points

• Mizuho initiated coverage on **Teladoc Health** with a **neutral** rating and a price target of **$10.00**, suggesting a potential upside of **22.03%** from the current price.
• Wells Fargo and Stifel Nicolaus both reduced their price targets for Teladoc to **$8.00**, while Canaccord Genuity set a target of **$12.00**, indicating varying outlooks among analysts.
• Insider trading activity included two executives selling shares totaling over **$67,000**, reflecting a **7.68%** and **18.32%** decrease in their respective holdings.

Analysts at Mizuho initiated coverage on shares of Teladoc Health (NYSE:TDOC - Get Free Report) in a research note issued to investors on Friday,Benzinga reports. The brokerage set a "neutral" rating and a $10.00 price target on the health services provider's stock. Mizuho's price target indicates a potential upside of 22.03% from the stock's current price.

Other equities research analysts also recently issued research reports about the company. Wells Fargo & Company reduced their price target on Teladoc Health from $10.00 to $8.00 and set an "equal weight" rating on the stock in a research report on Thursday, May 8th. Stifel Nicolaus reduced their target price on Teladoc Health from $9.00 to $8.00 and set a "hold" rating on the stock in a report on Thursday, May 1st. Canaccord Genuity Group reduced their target price on Teladoc Health from $14.00 to $12.00 and set a "buy" rating on the stock in a report on Thursday, May 1st. Needham & Company LLC reaffirmed a "hold" rating on shares of Teladoc Health in a report on Thursday, May 1st. Finally, Truist Financial reduced their target price on Teladoc Health from $10.00 to $9.00 and set a "hold" rating on the stock in a report on Tuesday, May 27th. Thirteen analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of "Hold" and an average price target of $9.67.

Teladoc Health Trading Down 4.5%

Shares of NYSE:TDOC opened at $8.20 on Friday. The company has a market capitalization of $1.44 billion, a P/E ratio of -1.38 and a beta of 1.84. Teladoc Health has a 1 year low of $6.35 and a 1 year high of $15.21. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.68 and a quick ratio of 1.64. The business's 50 day simple moving average is $7.63 and its 200 day simple moving average is $8.61.

Insiders Place Their Bets

In other Teladoc Health news, insider Adam C. Vandervoort sold 5,808 shares of Teladoc Health stock in a transaction dated Monday, June 2nd. The stock was sold at an average price of $6.86, for a total transaction of $39,842.88. Following the transaction, the insider directly owned 69,773 shares of the company's stock, valued at approximately $478,642.78. The trade was a 7.68% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Carlos Nueno sold 3,958 shares of Teladoc Health stock in a transaction dated Monday, June 2nd. The stock was sold at an average price of $6.86, for a total value of $27,151.88. Following the transaction, the insider directly owned 17,645 shares in the company, valued at $121,044.70. The trade was a 18.32% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 18,656 shares of company stock valued at $128,189. 0.58% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Capital Advisors Inc. OK bought a new position in shares of Teladoc Health in the 2nd quarter worth about $174,000. Bank Hapoalim BM bought a new stake in Teladoc Health in the 2nd quarter valued at about $777,000. Impact Investors Inc increased its position in Teladoc Health by 17.6% in the 2nd quarter. Impact Investors Inc now owns 21,620 shares of the health services provider's stock valued at $188,000 after buying an additional 3,232 shares in the last quarter. Ameritas Advisory Services LLC bought a new stake in Teladoc Health in the 2nd quarter valued at about $78,000. Finally, Brave Asset Management Inc. bought a new stake in Teladoc Health in the 2nd quarter valued at about $131,000. 76.82% of the stock is owned by institutional investors and hedge funds.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.